IS8428A - Innrennslislyf sem inniheldur (2R)-2-própýloktansýru sem virka efnisþáttinn - Google Patents
Innrennslislyf sem inniheldur (2R)-2-própýloktansýru sem virka efnisþáttinnInfo
- Publication number
- IS8428A IS8428A IS8428A IS8428A IS8428A IS 8428 A IS8428 A IS 8428A IS 8428 A IS8428 A IS 8428A IS 8428 A IS8428 A IS 8428A IS 8428 A IS8428 A IS 8428A
- Authority
- IS
- Iceland
- Prior art keywords
- active ingredient
- octanoic acid
- infusion containing
- propyl octanoic
- propyl
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Inorganic Chemistry (AREA)
- Dermatology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2003345125 | 2003-10-03 | ||
PCT/JP2004/014896 WO2005032538A1 (ja) | 2003-10-03 | 2004-10-01 | (2r)−2−プロピルオクタン酸を有効成分とする輸液製剤 |
Publications (1)
Publication Number | Publication Date |
---|---|
IS8428A true IS8428A (is) | 2006-04-25 |
Family
ID=34419442
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IS8428A IS8428A (is) | 2003-10-03 | 2006-04-25 | Innrennslislyf sem inniheldur (2R)-2-própýloktansýru sem virka efnisþáttinn |
Country Status (17)
Country | Link |
---|---|
US (1) | US20070066686A1 (is) |
EP (1) | EP1669066A4 (is) |
JP (1) | JP4715516B2 (is) |
CN (1) | CN1889941A (is) |
AU (1) | AU2004277828A1 (is) |
BR (1) | BRPI0414968A (is) |
CA (1) | CA2540671A1 (is) |
EC (1) | ECSP066476A (is) |
IL (1) | IL174691A0 (is) |
IS (1) | IS8428A (is) |
MA (1) | MA28143A1 (is) |
MX (1) | MXPA06003605A (is) |
NO (1) | NO20061458L (is) |
RU (1) | RU2006114834A (is) |
SG (1) | SG146690A1 (is) |
WO (1) | WO2005032538A1 (is) |
ZA (1) | ZA200602689B (is) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7980168B2 (en) * | 2007-06-26 | 2011-07-19 | Maurer Scott D | Hot beverage maker with filter deforming member |
US20100130619A1 (en) * | 2008-11-24 | 2010-05-27 | Joseph Schwarz | Pharmaceutical composition for parenteral administration of idebenone |
RU2549448C1 (ru) * | 2014-05-20 | 2015-04-27 | Екофарм Патент Менеджмент Аг | Сбалансированный инфузионный раствор |
CN104931424A (zh) * | 2015-05-06 | 2015-09-23 | 山东师范大学 | 一种改进的z扫描非线性测量的实验装置及方法 |
CN109593676B (zh) * | 2018-12-21 | 2023-04-07 | 江苏大学 | 一种用于酸菜发酵液中微生物分离的培养基及其制备方法 |
CA3129732A1 (en) * | 2019-02-14 | 2020-08-20 | North Grove Investments, Inc. | Compositions for maintaining the viability of living and static biological material, methods of making and the uses thereof |
RU2699222C1 (ru) * | 2019-04-29 | 2019-09-04 | Алексей Владимирович Воронов | Солевой электролитный раствор для проведения энтеральных инфузий |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0632008B1 (en) * | 1993-06-01 | 1998-02-04 | Ono Pharmaceutical Co., Ltd. | Pentanoic acid derivatives |
JPH0782146A (ja) * | 1993-07-23 | 1995-03-28 | Sagami Chem Res Center | 抗痴呆薬 |
JPH07285911A (ja) * | 1994-04-20 | 1995-10-31 | New Japan Chem Co Ltd | 脂肪族モノカルボン酸組成物 |
JPH0853351A (ja) * | 1994-08-11 | 1996-02-27 | Sagami Chem Res Center | 酵素阻害剤、血管新生抑制剤、および癌転移抑制剤 |
US6043223A (en) * | 1997-11-12 | 2000-03-28 | The Regents Of The University Of California | Enhanced opening of abnormal brain tissue capillaries |
TWI268921B (en) * | 1999-02-18 | 2006-12-21 | Ono Pharmaceutical Co | A process for preparing (2R)-2-propyloctanoic acid |
EP1295893A4 (en) * | 2000-05-31 | 2005-10-26 | Japan Science & Tech Agency | GINSENOSIDES FOR PROMOTING SKIN WEBERENEGENERATION |
KR100759771B1 (ko) * | 2000-07-18 | 2007-10-04 | 오노 야꾸힝 고교 가부시키가이샤 | 성상세포 기능 개선제를 유효 성분으로 함유하는 파킨슨병치료제 |
JP4706950B2 (ja) * | 2000-07-18 | 2011-06-22 | 小野薬品工業株式会社 | アストロサイト機能改善剤を有効成分として含有するパーキンソン病治療剤 |
EP2050468A1 (en) * | 2001-07-18 | 2009-04-22 | Ono Pharmaceutical CO., LTD. | Agent for treatment of cerebral ischemic diseases |
-
2004
- 2004-10-01 CN CNA2004800356843A patent/CN1889941A/zh active Pending
- 2004-10-01 EP EP04792178A patent/EP1669066A4/en not_active Withdrawn
- 2004-10-01 JP JP2005514508A patent/JP4715516B2/ja not_active Expired - Fee Related
- 2004-10-01 SG SG200807295-1A patent/SG146690A1/en unknown
- 2004-10-01 US US10/574,476 patent/US20070066686A1/en not_active Abandoned
- 2004-10-01 MX MXPA06003605A patent/MXPA06003605A/es not_active Application Discontinuation
- 2004-10-01 WO PCT/JP2004/014896 patent/WO2005032538A1/ja active Application Filing
- 2004-10-01 BR BRPI0414968-8A patent/BRPI0414968A/pt not_active IP Right Cessation
- 2004-10-01 RU RU2006114834/15A patent/RU2006114834A/ru not_active Application Discontinuation
- 2004-10-01 AU AU2004277828A patent/AU2004277828A1/en not_active Abandoned
- 2004-10-01 CA CA002540671A patent/CA2540671A1/en not_active Abandoned
-
2006
- 2006-03-30 IL IL174691A patent/IL174691A0/en unknown
- 2006-03-31 NO NO20061458A patent/NO20061458L/no not_active Application Discontinuation
- 2006-03-31 ZA ZA200602689A patent/ZA200602689B/en unknown
- 2006-04-03 EC EC2006006476A patent/ECSP066476A/es unknown
- 2006-04-25 IS IS8428A patent/IS8428A/is unknown
- 2006-05-02 MA MA28992A patent/MA28143A1/fr unknown
Also Published As
Publication number | Publication date |
---|---|
JP4715516B2 (ja) | 2011-07-06 |
CA2540671A1 (en) | 2005-04-14 |
EP1669066A1 (en) | 2006-06-14 |
IL174691A0 (en) | 2006-08-20 |
ZA200602689B (en) | 2007-06-27 |
SG146690A1 (en) | 2008-10-30 |
BRPI0414968A (pt) | 2006-11-07 |
ECSP066476A (es) | 2007-03-29 |
WO2005032538A1 (ja) | 2005-04-14 |
MXPA06003605A (es) | 2006-06-14 |
CN1889941A (zh) | 2007-01-03 |
NO20061458L (no) | 2006-07-03 |
JPWO2005032538A1 (ja) | 2006-12-14 |
AU2004277828A1 (en) | 2005-04-14 |
RU2006114834A (ru) | 2007-11-20 |
MA28143A1 (fr) | 2006-09-01 |
EP1669066A4 (en) | 2009-04-29 |
US20070066686A1 (en) | 2007-03-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IS8430A (is) | Lyf sem inniheldur (2R)-2-própýloktansýru sem virka efnisþáttinn | |
IL229510A0 (en) | A dosage form containing pantoprazole as an active ingredient | |
ZA200608029B (en) | Nitrogenous fused-ring derivatives, medicinal compositions containing the derivatives, and use thereof as drugs | |
PL372084A1 (en) | 8-azaprostaglandin derivative compounds and drugs containing the compounds as the active ingredient | |
TWI328576B (en) | Diketohydrazine derivative compound, medicament containing same as active ingredient | |
IL176872A0 (en) | Amide derivatives, process for the preparation thereof and use thereof as an insecticide | |
PL1543851T3 (pl) | Wszczepialne urządzenie do podawania substancji czynnej | |
NO20040564L (no) | Karboksylsyrederivatforbindelser og legemidler omfattende disse forbindelser som den aktive bestanddel | |
ZA200705750B (en) | Compositions and methods for stabilizing active pharmaceutical ingredients | |
ZA200605507B (en) | Active substance combinations having insecticidal properties | |
IS8428A (is) | Innrennslislyf sem inniheldur (2R)-2-própýloktansýru sem virka efnisþáttinn | |
HK1105202A1 (en) | Heterocyclic compound and anti-malignant-tumor agent containing the same as active ingredient | |
HK1129111A1 (en) | Tiotropium salts, pharmaceutical formulations containing the salts and the use thereof | |
EP1731609A4 (en) | INHIBITOR OF THE EXPRESSION OF RAD51, MEDICAMENT CONTAINING THE INHIBITOR AS ACTIVE INGREDIENT AND USE THEREOF | |
NO20054214D0 (no) | Iminoeterderivatforbindelser og legemidler inneholdende forbindelsene som den aktive bestanddel | |
IL174336A0 (en) | Carboxylic acid compounds and medicinal compositions containing the same as the active ingredient | |
HUP0400155A3 (en) | N-phenylarylsulfonamide compound, drug containing the compound as active ingredient, intermediate for the compound, and processes for producing the same | |
EP1602362A4 (en) | DRUG COMPOSITION COMPRISING AN ADHESIVE ACTIVE INGREDIENT IN HIGH CONCENTRATION TO A SPHERICAL CORE | |
EP1608395A4 (en) | ANTICROPE WITH LK8 PROTEIN AS AN ACTIVE SUBSTANCE | |
IL181216A (en) | 5, 3-SICO-4-NORKOLSTAN DERIVATIVES AND PHARMACEUTICAL COMPONENTS CONTAINING @ THEM | |
ITRM20040223A1 (it) | Medicamento per il trattamento delle infezioni fungine, in particolare dell'aspergillosi. | |
FR2890312B1 (fr) | Procede d'obtention d'un principe actif repulpant, principe actif obtenu et compositions cosmetiques l'incluant | |
IS7290A (is) | Lyfjasamsetningar sem innihalda risperidone | |
ATE355830T1 (de) | Schmelzformulierte, multipartikuläre orale darreichungsform enthaltend clavulansäure | |
EP1581196A4 (en) | ACID LABILIC DRUG COMPOSITIONS |